Search

Your search keyword '"Càncer -- Tractament"' showing total 86 results

Search Constraints

Start Over You searched for: Descriptor "Càncer -- Tractament" Remove constraint Descriptor: "Càncer -- Tractament" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
86 results on '"Càncer -- Tractament"'

Search Results

1. Wireless electrostimulation for cancer treatment: an integrated nanoparticle/coaxial fiber mesh platform

2. Caracterización técnica de vehículos y biomateriales tratados con plasma de acuerdo con regulatoria

3. Comparación de métodos de cálculo de dosis empleados en la planificación de radioterapia externa en condiciones de extrema inhomogeneidad

4. Optimization of agarose-based composite hydrogels for delivery of reactive species generated in biopolymer solutions by non-thermal plasma treatment

5. Comparación de métodos de cálculo de dosis empleados en la planificación de radioterapia externa en condiciones de extrema inhomogeneidad

6. Molecular Determinants for the Activation/Inhibition of Bak Protein by BH3 Peptides

7. Optimization of agarose-based composite hydrogels for delivery of reactive species generated in biopolymer solutions by non-thermal plasma treatment

8. Two-photon lithography for fabrication of implantable drug delivery devices

9. AZ12756122, a novel fatty acid synthase inhibitor, decreases resistance features in EGFR-TKI resistant EGFR-mutated NSCLC cell models

10. Engineered microtissues for the bystander therapy against cancer

11. Plasma-conditioned liquids as anticancer therapies in vivo: current state and future directions

12. A Nuclear-Directed Ribonuclease Variant Targets Cancer Stem Cells and Inhibits Migration and Invasion of Breast Cancer Cells

13. Investigating the atmospheric pressure plasma jet modification of a photo-crosslinkable hydrogel

14. Molecular determinants for the activation/inhibition of bak protein by BH3 peptides

15. Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

16. Plasma-conditioned liquids as anticancer therapies in vivo: current state and future directions

17. The receptor of the colony-stimulating factor-1 (CSF-1R) is a novel prognostic factor and therapeutic target in follicular lymphoma

18. Engineered microtissues for the bystander therapy against cancer

19. In the literature: december 2021

20. A pilot study to evaluate early predictive value of thorax perfusion-CT in advanced NSCLC

21. Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

22. Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models

23. Sex differences in oncogenic mutational processes

24. Modulation of mitochondrial metabolic reprogramming and oxidative stress to overcome chemoresistance in cancer

25. Comparativa de efectos directos e indirectos de plasmas atmosféricos para terapia biomédica

26. Metabolomic mapping of cancer stem cells for reducing and exploiting tumor heterogeneity

27. Metformin as an archetype immuno-metabolic adjuvant for cancer immunotherapy

28. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

29. Epigenetic silencing of TGFBI confers resistance to trastuzumab in human breast cancer

30. Comparativa de efectos directos e indirectos de plasmas atmosféricos para terapia biomédica

31. Estudi de la interacció entre l’EGF i el seu receptor EGFR per a crear lligands modificats i fer teràpia dirigida contra el cáncer

32. Electrospray loading and release of hydrophobic gramicidin in polyester microparticles

34. The multikinase inhibitor EC‐70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

35. Investigating the atmospheric pressure plasma jet modification of a photo-crosslinkable hydrogel

36. The multikinase inhibitor EC-70124 synergistically increased the antitumor activity of doxorubicin in sarcomas

37. Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer

38. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation

39. Overexpression of S100A4 in human cancer cell lines resistant to methotrexate

40. Efecte de la glicosilació sobre l’activitat i la resposta a tractaments de l’EGFR

41. Cytokeratin profile of basal cell carcinomas according to the degree of sun exposure and to the anatomical localization

42. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16

44. Weighing biointeractions between fibrin (ogen) and clot-binding peptides using microcantilever sensors

46. Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

47. Translational reprogramming in tumour cells can generate oncoselectivity in viral therapies

48. Targeted cancer therapy: interactions with other medicines

49. HIF-1α- Targeting Acriflavine Provides Long Term Survival and Radiological Tumor Response in Brain Cancer Therapy

50. Weighing biointeractions between fibrin (ogen) and clot-binding peptides using microcantilever sensors

Catalog

Books, media, physical & digital resources